Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1364-8535
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhage: a propensity score-overlap weighted analysis ; volume:26 ; number:1 ; day:16 ; month:6 ; year:2022 ; pages:1-13 ; date:12.2022
Critical care ; 26, Heft 1 (16.6.2022), 1-13, 12.2022
- Creator
-
Costa, Olivia S.
Connolly, Stuart J.
Sharma, Mukul
Beyer-Westendorf, Jan
Christoph, Mary J.
Lovelace, Belinda
Coleman, Craig I.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13054-022-04043-8
- URN
-
urn:nbn:de:101:1-2022081021523671793865
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Costa, Olivia S.
- Connolly, Stuart J.
- Sharma, Mukul
- Beyer-Westendorf, Jan
- Christoph, Mary J.
- Lovelace, Belinda
- Coleman, Craig I.
- SpringerLink (Online service)
Other Objects (12)
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Role of prothrombin complex concentrate in perioperative coagulation therapy
Innovative Antithrombotika : Ticagrelor, Prasugrel, Elinogrel, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, Vorapaxar, Atopaxar
Antikoagulation bei Vorhofflimmern – Dabigatran, Rivaroxaban oder Apixaban – die Qual der Wahl?
Shorter hospital stays in epistaxis patients taking Rivaroxaban and Apixaban vs. Phenprocoumon
Kürzere Verweildauer bei Epistaxis-Patienten unter Rivaroxaban und Apixaban im Vergleich zu Phenprocoumon
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Role of prothrombin complex concentrate in perioperative coagulation therapy
Innovative Antithrombotika : Ticagrelor, Prasugrel, Elinogrel, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, Vorapaxar, Atopaxar
Antikoagulation bei Vorhofflimmern – Dabigatran, Rivaroxaban oder Apixaban – die Qual der Wahl?
Shorter hospital stays in epistaxis patients taking Rivaroxaban and Apixaban vs. Phenprocoumon
Kürzere Verweildauer bei Epistaxis-Patienten unter Rivaroxaban und Apixaban im Vergleich zu Phenprocoumon
Theoretical Modeling of Coagulation Management With Therapeutic Plasma or Prothrombin Complex Concentrate
Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Correction to: Treatment of adults with intracranial hemorrhage on apixaban or rivaroxaban with prothrombin complex concentrate products
Activated prothrombin complex concentrate to reverse the factor Xa inhibitor (apixaban) effect before emergency surgery: a case series
Preparation of a Nonthrombogenic Prothrombin Complex Concentrate
Four-factor prothrombin complex concentrate improves thrombin generation and prothrombin time in patients with bleeding complications related to rivaroxaban: a single-center pilot trial
3-Factor prothrombin complex concentrate versus 4-factor prothrombin complex concentrate for the reversal of oral factor Xa inhibitors
Role of prothrombin complex concentrate in perioperative coagulation therapy
Innovative Antithrombotika : Ticagrelor, Prasugrel, Elinogrel, Rivaroxaban, Apixaban, Edoxaban, Dabigatran, Vorapaxar, Atopaxar
Antikoagulation bei Vorhofflimmern – Dabigatran, Rivaroxaban oder Apixaban – die Qual der Wahl?
Shorter hospital stays in epistaxis patients taking Rivaroxaban and Apixaban vs. Phenprocoumon
Kürzere Verweildauer bei Epistaxis-Patienten unter Rivaroxaban und Apixaban im Vergleich zu Phenprocoumon